The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Repligen neuro research attracts major grant funding

August 2, 2010 10:37 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Waltham biopharmaceuticals firm Repligen Corp. has received three grants, totaling in excess of $6 million, to apply to its HDAC inhibitor research for neurodegenerative diseases like Friedreich’s Ataxia and Huntington’s Disease.

NeoProfen (ibuprofen lysine) Injection: Recall and Shortage - Risk of Particulate Matter

August 2, 2010 10:30 am | by U.S. Food & Drug Administration | News | Comments

Potential for particulate matter to result in serious adverse effects.


Summary Box: Premiums drive Humana's 2Q growth

August 2, 2010 9:45 am | by The Associated Press | News | Comments

MEDICARE'S ADVANTAGE: Double-digit enrollment growth in lucrative Medicare Advantage plans helped lift Humana Inc.'s second-quarter profit 21 percent and the insurer raised its full-year outlook.BOTTOM LINE: The company earned $340.1 million, or $2 per share, up from $281.8 million, or $1.67 per...


Charles River Labs sees drop in Q2 numbers

August 2, 2010 9:41 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Just days after announcing the cancellation of its planned $1.6 billion buy of China’s WuXi PharmaTech (Cayman) Inc., Charles River Laboratories International Inc. reports that it numbers for the second quarter of 2010 were down versus the same period last year.


Disparities in cardiovascular risk based more on socioeconomic status than race, ethnicity

August 2, 2010 9:41 am | by EurekAlert | News | Comments

(University of California - Los Angeles) A new study suggests that disparities in cardiovascular disease risk in the United States are due less to race or ethnicity than to socioeconomic status. The researchers found that there are large differences in risk by socioeconomic status...


Dose optimization workshop helps reduce radiation dose associated with MDCT scans

August 2, 2010 9:41 am | by EurekAlert | News | Comments

(American College of Radiology / American Roentgen Ray Society) Numerous radiology practices were able to significantly reduce the radiation dose associated with multi-detector computed tomography scans by participating in a one day dose optimization workshop provided by the Royal...


Insights from SUSS workshop on thin wafer handling at Semicon'West 2010

August 2, 2010 9:40 am | by I-Micronews | News | Comments

At the recent Semicon exhibition in San Francisco Suss assembled a group of partners and technical and market experts (shown below) to discuss the status of 3D IC and specifically temporary bonding and thin wafer handling.

RoundTable Healthcare Partners Portfolio Company, Aspen Surgical Products, Inc., Acquires Bard-Parker™ Surgical Blades and Scalpels Business

August 2, 2010 9:38 am | by Bio-Medicine.Org | News | Comments

LAKE FOREST, Ill. , Aug. 2 /- RoundTable Healthcare Partners ("RoundTable"), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that its portfolio company, Aspen Surgical Products, Inc. (" Aspen "), has acquired the Bard-Parker...


Haemonetics 1Q profit slips but tops expectations

August 2, 2010 7:45 am | by The Associated Press | News | Comments

Blood collection and processing systems maker Haemonetics Corp. said Monday its net income dipped 1 percent in the fiscal first quarter but still topped Wall Street expectations as strong sales of platelet disposables offset a decline in its plasma business.Haemonetics said earnings slipped to...

LifePoint Hospitals 2Q earnings climb 43 percent

August 2, 2010 6:45 am | by The Associated Press | News | Comments

Rural hospital operator LifePoint Hospitals Inc. said Monday its second-quarter net income climbed 43 percent compared to last year, when rising expenses helped knock down earnings.The Brentwood, Tenn., company said it earned $37.6 million, or 69 cents per share, in the three months that ended...

Stocks start month with big gains

August 2, 2010 6:45 am | by STEPHEN BERNARD - AP Business Writer - Associated Press | News | Comments

Stocks kicked off the new month with a big gain Monday, after strong manufacturing reports around the world and upbeat earnings added to hopes that the global recovery is picking up pace.The Dow Jones industrial average jumped almost 175 points. Broader indexes also rose nearly 2 percent.The...

BD Completes Sales of Ophthalmic Systems Unit and Surgical Blades Product Platform

August 2, 2010 6:38 am | by Bio-Medicine.Org | News | Comments

FRANKLIN LAKES, N.J. , Aug. 2 /- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, today announced the completion of the sale of its Ophthalmic Systems unit to RoundTable Healthcare Partners and the sale of its surgical blades product platform...


FDA Approves Merz Pharmaceuticals' Xeomin® (incobotulinumtoxinA) for the Treatment of Cervical Dystonia and Blepharospasm

August 2, 2010 6:37 am | by Bio-Medicine.Org | News | Comments

GREENSBORO, N.C. , Aug. 2 /- Merz Pharmaceuticals today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Xeomin ® (incobotulinumtoxinA), a botulinum toxin type A for the treatment of adults with cervical dystonia or blepharospasm. According to...


OraVerse® Named as One of Dentistry Today's 'Top 100 Products' for Second Year

August 2, 2010 6:34 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO , Aug. 2 /- Novalar Pharmaceuticals, Inc., a specialty pharmaceutical company focused in dental, today announced that OraVerse®, the company's premier pharmaceutical product, has again been selected by leading dental industry magazine Dentistry Today as one of its 'Top 100...


Cornerstone Therapeutics Announces Collaboration with The Cough Company

August 2, 2010 6:34 am | by Bio-Medicine.Org | News | Comments

CARY, N.C. , Aug. 2 /- Cornerstone Therapeutics Inc. (Nasdaq: CRTX ) ("Cornerstone" or the "Company"), a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the respiratory and related markets, today announced that the...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.